alexa Antithrombotic Cancer Associated Thrombosis: It May Change | OMICS International| Abstract
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Blood Lymph 2018, Vol 1(1): 007
  • DOI: 10.4172/2165-7831.S1-007

Antithrombotic Cancer Associated Thrombosis: It May Change

Andrea Fontanella1, Mauro Campanini2, Francesco Dentali3, Gualberto Gussoni4*, Dario Manfellotto5, Mauro Silingardi6, Giancarlo Agnelli7 and Pierpaolo Di Micco1
1Department of Internal Medicine, Fatebenefratelli Hospital, Napoli, Italy
2Department of Internal Medicine, Hospital ‘Maggiore della Carità, Novara, Italy
3Department of Internal Medicine, Hospital ‘Luini Confalonieri’, Luino, Italy
4Research Department, FADOI Foundation, Milano, Italy
5Department of Internal Medicine, Fatebenefratelli Hospital-AFaR, Roma, Italy
6Department of Internal Medicine A, Maggiore Hospital, Bologna, Italy
7Department of Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy
*Corresponding Author : Gualberto Gussoni, Research Department, FADOI Foundation, Piazza Cadorna, Milano, Italy, Tel: +390285355188, Email: [email protected]

Received Date: Dec 20, 2018 / Accepted Date: Dec 25, 2018 / Published Date: Dec 29, 2018


Active treatment of acute venous thromboembolism without active bleeding is primarily based on the administration of LMWH, according to international guidelines. However, recent studies have provided data on direct oral anticoagulants that offer interesting new perspectives concerning efficacy in the prevention of recurrent VTE and the safety of these drugs in this particular patient population.

Keywords: VTE; Venous thromboembolism; Rivaroxaban

Citation: Fontanella A, Campanini M, Dentali F, Gussoni G, Manfellotto D, et al. (2018) Antithrombotic Cancer Associated Thrombosis: It May Change. J Blood Lymph S1: 007. Doi: 10.4172/2165-7831.S1-007

Copyright: © 2018 Fontanella A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Relevant Topics
Article Usage
  • Total views: 731
  • [From(publication date): 0-0 - Dec 07, 2019]
  • Breakdown by view type
  • HTML page views: 690
  • PDF downloads: 41